Loading...
XSHE
300015
Market cap14bUSD
Dec 05, Last price  
11.30CNY
1D
0.62%
1Q
-12.54%
Jan 2017
-14.97%
IPO
-12.20%
Name

Aier Eye Hospital Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300015 chart
P/E
29.45
P/S
4.99
EPS
0.38
Div Yield, %
1.34%
Shrs. gr., 5y
1.00%
Rev. gr., 5y
16.00%
Revenues
20.98b
+3.02%
191,188,834314,903,815439,120,734606,450,103864,877,4501,310,624,4721,640,130,4501,984,967,2872,402,047,6163,165,580,4714,000,401,6715,962,845,5598,008,573,9549,990,103,97611,912,409,98415,000,809,43816,109,946,68720,367,156,73820,982,894,148
Net income
3.56b
+5.87%
14,591,52138,979,51661,366,55592,489,402120,309,791171,927,760182,546,813223,495,554309,186,277428,043,981557,467,244742,514,5371,008,937,3481,378,920,9701,723,805,3352,323,343,9572,524,230,8403,358,871,5353,556,055,831
CFO
4.88b
-16.86%
36,904,48992,187,299121,174,149169,137,874239,966,170257,108,449301,818,986412,651,458453,683,706522,168,231675,098,1661,330,404,5121,399,870,3982,078,432,7343,343,611,3254,084,103,9584,490,674,8115,871,890,0914,881,686,201
Dividend
Jun 06, 20240.15002 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.
IPO date
Oct 30, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT